PZ Cormay S.A. Logo

PZ Cormay S.A.

Manufactures and distributes IVD reagents and analyzers for human and veterinary medicine.

CRM | WAR

Overview

Corporate Details

ISIN(s):
PLCMRAY00029
LEI:
2594006HZJ8OSNK56U87
Country:
Poland
Address:
Warszawa Puławska 303, 02-785 Warszawa
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

PZ Cormay S.A. is a manufacturer and distributor of comprehensive solutions for the in-vitro diagnostics (IVD) market. With nearly 40 years of experience, the company specializes in producing high-quality diagnostic reagents and distributing advanced laboratory analyzers. Its product portfolio covers key areas of laboratory medicine, including clinical chemistry, hematology, immunology, and coagulology. The group integrates its reagent manufacturing expertise with the advanced hematology technology of its Swiss subsidiary, Orphee. Cormay provides reliable, high-performance, and cost-effective diagnostic systems to a global network of distributors, clinics, and laboratories for both human and veterinary medicine, committed to delivering trusted test results to aid in accurate medical diagnoses.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-01 09:25
Pre-Annual General Meeting Information
zal01_Ogloszenie_projekty_uchwal_NWZ_PZ_CORMAY_S.A._27.10.2025.pdf
Polish 310.6 KB
2025-10-01 09:25
Report Publication Announcement
Ogłoszenie o zwołaniu NWZ PZ CORMAY S.A. na dzień 27.10.2025 r. (wraz z projekt…
Polish 152 bytes
2025-09-26 07:51
Audit Report / Information
zal02_4._Raport_z_przegladu_PZ_CORMAY_S.A._I_polrocze_2025.pdf
Polish 383.3 KB
2025-09-26 07:51
Audit Report / Information
zal03_3._Raport_z_przegladu_GK_CORMAY_I_polrocze_2025.pdf
Polish 364.5 KB
2025-09-26 07:51
Management Discussion and Analysis
zal04_2._Sprawozdanie_Zarzadu_GK_CORMAY_I_polrocze_2025.pdf
Polish 739.1 KB
2025-09-26 07:51
Interim Report
zal01_1._Sprawozdania_finansowe_GK_CORMAY_PZ_CORMAY_S.A_I_polrocze_2025.pdf
Polish 1.8 MB
2025-09-24 15:26
Related Party Transaction
Zgoda Rady Nadzorczej PZ CORMAY S.A. na zawarcie oraz zawarcie aneksów do umów …
Polish 2.0 KB
2025-05-22 12:27
Post-Annual General Meeting Information
Powołanie osób zarządzających PZ CORMAY S.A. - Content (PL)
Polish 2.9 KB
2025-05-22 12:27
Post-Annual General Meeting Information
Powołanie osób nadzorujących PZ CORMAY S.A. - Content (PL)
Polish 7.4 KB
2025-05-22 12:26
Declaration of Voting Results & Voting Rights Announcements
zal01_RB_5_2025.pdf
Polish 122.4 KB
2025-05-22 12:26
Report Publication Announcement
Lista akcjonariuszy posiadających co najmniej 5% liczby głosów na ZWZ PZ CORMAY…
Polish 152 bytes
2025-05-22 12:25
Post-Annual General Meeting Information
zal01_RB_4_2025.pdf
Polish 357.2 KB
2025-05-22 12:25
Report Publication Announcement
Treść uchwał ZWZ PZ CORMAY S.A., które odbyło się w dniu 22.05.2025 r. - Conten…
Polish 152 bytes
2025-05-16 07:36
Quarterly Report
zal01_Raport_I_kwartal_2025_GK_CORMAY_PZ_CORMAY_S.A..pdf
Polish 1.7 MB
2025-04-25 11:03
Remuneration Information
zal03_Ocena_br_sprawozdanie_o_wynagrodzeniach_2024.pdf
Polish 396.7 KB

Automate Your Workflow. Get a real-time feed of all PZ Cormay S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for PZ Cormay S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Can-Fite BioPharma Ltd. Logo
Develops oral small-molecule drugs targeting A3AR for oncology and inflammatory diseases.
Israel CANF
Cannovum Cannabis AG Logo
Importer & producer of medical cannabis, expanding into recreational cultivation infrastructure.
Germany 27N0
Cantourage Group SE Logo
A European platform producing and distributing medical cannabis products to pharmacies.
Germany HIGH
CAREGEN CO.,LTD. Logo
Develops patented peptides and growth factors for medical aesthetics, pharma, and anti-aging markets.
South Korea 214370
CELADON PHARMACEUTICALS PLC Logo
Vertically integrated pharma developing cannabis medicines for chronic pain.
United Kingdom CEL
Celemics, Inc. Logo
Develops custom NGS panels and bioinformatics for research and clinical diagnostics.
South Korea 331920
Develops & manufactures radiopharmaceuticals for cancer diagnosis and therapy.
South Korea 308430
CELL BIOTECH CO ., LTD Logo
A global biotech firm offering probiotic raw materials, OEM/ODM services, and consumer brands.
South Korea 049960
Cellectis Logo
Develops 'off-the-shelf' CAR T-cell cancer immunotherapies using TALEN® gene-editing.
France ALCLS
Cellid Co., Ltd. Logo
Biotech firm developing proprietary vaccine platforms for cancer and infectious diseases.
South Korea 299660

Talk to a Data Expert

Have a question? We'll get back to you promptly.